10.1038/nature07540 Nature
While the SAFE Drugs Act remains under legislative consideration, the FDA and state attorneys general appear to already be implementing more aggressive oversight measures until a more stringent oversight framework is in place
If you are considering this treatment, consult with Dr
View Study [3]"Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity" Garvey WT et al., 2025 Finding: The REDEFINE 1 Phase 3 trial showed CagriSema achieved 20.4% weight loss versus 3% with placebo over 68 weeks in 3,417 participants
Switching from an off-label Ozempic prescription to an FDA-approved weight loss medication could also improve insurance approval chances, as companies are typically more willing to cover medications for their intended uses
You might start noticing the first signs of new, baby hairs and less shedding in as little as three months